The pharmaceutical industry in Denmark is a key sector of the Danish economy. The country has a considerable biopharmaceutical industry, with several domestic companies researching and manufacturing pharmaceutical products. Revenues generated by this industry increased overall during the past decade and grew significantly in the last four years.
Novo Nordisk tops them all
The largest of the Danish pharmaceutical companies is without doubt Novo Nordisk, whose main area consists of medicines and treatments for diabetes as well as related products like pens and needles. Diabetes treatment products generated most of Novo Nordisk’s sales, but they also focus on areas such as hormone replacement therapy and pharmaceuticals for treatment of other serious chronic diseases, like obesity, haemophilia, growth disorders. Novo Nordisk’s annual net profit increased every year during the last ten years, and the company is also the largest employer among the pharmaceutical companies in Denmark, with more than 45 thousand employees.
Other important companies
Two other large pharmaceutical companies headquartered in the country are H. Lundbeck, focusing on pharmaceuticals for psychiatric and neurological diseases, and Leo Pharma, the main product being medication for skin diseases. Other major Danish companies are Orifarm Group, ALK-Abello, and Xellia Pharmaceuticals, among others.
Pharmacies dominate sales
Most of the pharmaceutical spending in Denmark is on pharmaceuticals for inpatient care, followed by prescription pharmaceuticals. For pharmacies, which are the main channel for pharmaceutical sales in the country, almost three fourths of revenues come from prescribed pharmaceuticals.
This text provides general information. Statista assumes no
liability for the information given being complete or correct.
Due to varying update cycles, statistics can display more up-to-date
data than referenced in the text.
In the following 5 chapters, you will quickly find the 26 most important statistics relating to "Pharmaceutical industry in Denmark ".